| Recruiting | Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failur NCT06770023 | Mayo Clinic | Phase 1 |
| Not Yet Recruiting | GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chron NCT07516379 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Not Yet Recruiting | Decreasing Edema With a Novel OCS Solution Trial NCT07340710 | TransMedics | N/A |
| Recruiting | Bronchial Response to Exercise After Double Lung Transplantation NCT07035743 | Chang Gung Memorial Hospital | — |
| Recruiting | Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients NCT06476132 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | US National TOP Registry NCT06513091 | TransMedics | — |
| Recruiting | TEE and Dysphagia in Lung Transplantation NCT06089434 | University of California, Los Angeles | N/A |
| Enrolling By Invitation | Protest Trial: TXA vs Saline NCT06422273 | Corewell Health West | Phase 3 |
| Completed | Ultrasound Assessment of Rectus Femoris Cross-sectionnal Area Following Lung Transplantation NCT06268171 | Hopital Foch | — |
| Recruiting | Tocilizumab in Lung Transplantation NCT06033196 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Unknown | Identification of Patient Important Outcomes in Lung Transplantation NCT06066229 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | A Study of Latin Dance for Post- Lung Transplant NCT05924113 | Mayo Clinic | N/A |
| Active Not Recruiting | 10°C vs 4°C Lung Preservation RCT NCT05898776 | University Health Network, Toronto | N/A |
| Active Not Recruiting | The Effect of Nutrition and BMI on on Lung Capacity, Functional Capacity and Mortality in End-Stage Lung Patie NCT06283680 | Aylin Seylam Küşümler | — |
| Recruiting | Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates NCT05426200 | Mayo Clinic | N/A |
| Completed | TorEx Lung Perfusion System NCT05656404 | University Health Network, Toronto | N/A |
| Withdrawn | Can Mobility Technicians Provide Value to Hospitalized Patients? NCT03874767 | Vanderbilt University Medical Center | N/A |
| Recruiting | DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies NCT05671887 | Northwestern University | — |
| Recruiting | A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation NCT05547698 | Mayo Clinic | N/A |
| Withdrawn | Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates NCT05404919 | University of Pennsylvania | Phase 2 |
| Recruiting | A2 to O Lung Transplants NCT05581745 | University Health Network, Toronto | N/A |
| Unknown | Optimization of Donor-Recipient Matching in Lung Transplantation NCT05195853 | Fondation Hôpital Saint-Joseph | — |
| Completed | Letermovir for CMV Prevention After Lung Transplantation NCT05041426 | Fernanda P Silveira, MD, MS | Phase 2 |
| Completed | Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Dise NCT04857814 | University of Alberta | N/A |
| Withdrawn | PRETELL: PREvention of TELomere-related Complications After Lung Transplant NCT04807309 | Brigham and Women's Hospital | Phase 1 / Phase 2 |
| Completed | Planned Semi-Elective Lung Tx Study NCT04601818 | University of Florida | N/A |
| Terminated | Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders NCT02748798 | Thunder Bay Regional Health Research Institute | EARLY_Phase 1 |
| Completed | Envarsus XR in Lung Transplant NCT04420195 | NYU Langone Health | Phase 2 |
| Completed | Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System NCT04521569 | University of Maryland, Baltimore | EARLY_Phase 1 |
| Completed | Primary Graft Dysfunction, Pronation, Bilateral Lung Transplants NCT06159933 | University of Padova | N/A |
| Recruiting | An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transpl NCT05101460 | XVIVO Perfusion | — |
| Completed | Health Coaching to Improve Self-Management in Thoracic Transplant Candidates NCT03150095 | Mayo Clinic | N/A |
| Completed | Expanding the Pool in Lung Transplantation NCT03377478 | Pablo Sanchez | Phase 1 |
| Completed | Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients NCT04023760 | University of Saskatchewan | Phase 4 |
| Unknown | Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to H NCT04244734 | Hospital Universitari Vall d'Hebron Research Institute | N/A |
| Recruiting | The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Re NCT03886961 | University of Florida | N/A |
| Unknown | Comparative Study Between Sternal Closure With Sternalock® Blue Versus Steel Wire Submitted To Bilateral Anter NCT05055739 | University of Sao Paulo General Hospital | N/A |
| Completed | Post-operative, Inpatient Rehabilitation After Lung Transplant Evaluation NCT03095859 | The Alfred | N/A |
| Active Not Recruiting | Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease NCT03562728 | University of Maryland, Baltimore | N/A |
| Completed | Right Ventricle Dysfunction in Patients Undergoing Lung Transplant NCT05855148 | Policlinico Hospital | — |
| Completed | Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning NCT03987113 | Hopital Foch | — |
| Completed | Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grad NCT03226431 | Duke University | Phase 1 |
| Unknown | Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation NCT03072589 | Christine Lau, MD | Phase 1 |
| Completed | PREDICT Cytomegalovirus (CMV) NCT03300882 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilit NCT03299504 | Indiana University Health Methodist Hospital | — |
| Terminated | Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment NCT03207399 | Duke University | Phase 4 |
| Completed | High-Intensity Training Following Lung Transplantation NCT03155074 | Oslo University Hospital | N/A |
| Completed | Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients NCT03167528 | Hopital Foch | N/A |
| Recruiting | Thoracic Specimen Registry NCT04118660 | Mayo Clinic | — |
| Completed | The Effects of IMT on Exercise Capacity, Dyspnea and Lung Functions in LTx NCT03505697 | Istanbul Medipol University Hospital | N/A |
| Completed | CLAD Phenotype Specific Risk Factors and Mechanisms NCT02631720 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | B Cell Induction in Pediatric Lung Transplantation NCT02266888 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Unknown | Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation NCT02235610 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Completed | International EXPAND Lung Pivotal Trial NCT01963780 | TransMedics | N/A |
| Unknown | Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs NCT01365429 | XVIVO Perfusion | N/A |
| Completed | Immuno-humoral Rejection Markers in Pulmonary Transplant NCT01791166 | Hopital Foch | N/A |
| Terminated | CIS001 Extension Study of Cyclosporine Inhalation Solution NCT00938236 | APT Pharmaceuticals, Inc. | Phase 3 |
| Completed | Viral Triggers in Pediatric Lung Transplantation NCT00891865 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients NCT00908830 | University of Michigan | — |
| Completed | Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival F NCT00755781 | APT Pharmaceuticals, Inc. | Phase 3 |
| Completed | Alveoscopy, Endoscopic Confocal Microscopy and Lung Rejection, Parenchymal Lung Diseases in Vivo NCT01033201 | Mayo Clinic | — |
| Withdrawn | Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation NCT00592306 | University of California, Los Angeles | Phase 3 |
| Completed | Mechanisms of Lung Allograft Rejection NCT00340418 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Terminated | Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide NCT00041574 | Mallinckrodt | Phase 2 |
| No Longer Available | Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients NCT00633373 | APT Pharmaceuticals, Inc. | — |